FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2200671523> ?p ?o ?g. }

• W2200671523 endingPage "193" @default.
• W2200671523 startingPage "178" @default.
• W2200671523 abstract "Zoledronate (Zol) is a third-generation bisphosphonate that is widely used as an anti-resorptive agent for the treatment of cancer bone metastasis. While there is preclinical data indicating that bisphosphonates such as Zol have direct cytotoxic effects on cancer cells, such effect has not been firmly established in the clinical setting. This is likely due to the rapid absorption of bisphosphonates by the skeleton after intravenous (i.v.) administration. Herein, we report the reformulation of Zol using nanotechnology and evaluation of this novel nanoscale metal-organic frameworks (nMOFs) formulation of Zol as an anticancer agent. The nMOF formulation is comprised of a calcium zoledronate (CaZol) core and a polyethylene glycol (PEG) surface. To preferentially deliver CaZol nMOFs to tumors as well as facilitate cellular uptake of Zol, we incorporated folate (Fol)-targeted ligands on the nMOFs. The folate receptor (FR) is known to be overexpressed in several tumor types, including head-and-neck, prostate, and non-small cell lung cancers. We demonstrated that these targeted CaZol nMOFs possess excellent chemical and colloidal stability in physiological conditions. The release of encapsulated Zol from the nMOFs occurs in the mid-endosomes during nMOF endocytosis. In vitro toxicity studies demonstrated that Fol-targeted CaZol nMOFs are more efficient than small molecule Zol in inhibiting cell proliferation and inducing apoptosis in FR-overexpressing H460 non-small cell lung and PC3 prostate cancer cells. Our findings were further validated in vivo using mouse xenograft models of H460 and PC3. We demonstrated that Fol-targeted CaZol nMOFs are effective anticancer agents and increase the direct antitumor activity of Zol by 80–85% in vivo through inhibition of tumor neovasculature, and inhibiting cell proliferation and inducing apoptosis." @default.
• W2200671523 created "2016-06-24" @default.
• W2200671523 creator A5004908033 @default.
• W2200671523 creator A5007381505 @default.
• W2200671523 creator A5021903894 @default.
• W2200671523 creator A5033300046 @default.
• W2200671523 creator A5033510051 @default.
• W2200671523 creator A5041411617 @default.
• W2200671523 creator A5042404397 @default.
• W2200671523 creator A5047498651 @default.
• W2200671523 creator A5081615205 @default.
• W2200671523 creator A5083728536 @default.
• W2200671523 date "2016-03-01" @default.
• W2200671523 modified "2023-10-14" @default.
• W2200671523 title "Folate-targeted pH-responsive calcium zoledronate nanoscale metal-organic frameworks: Turning a bone antiresorptive agent into an anticancer therapeutic" @default.
• W2200671523 cites W1532955823 @default.
• W2200671523 cites W1541912458 @default.
• W2200671523 cites W1549522322 @default.
• W2200671523 cites W1600510649 @default.
• W2200671523 cites W1948560807 @default.
• W2200671523 cites W1964957951 @default.
• W2200671523 cites W1966153114 @default.
• W2200671523 cites W1970239046 @default.
• W2200671523 cites W1970993628 @default.
• W2200671523 cites W1971877746 @default.
• W2200671523 cites W1982855449 @default.
• W2200671523 cites W1989230986 @default.
• W2200671523 cites W2014647709 @default.
• W2200671523 cites W2017066134 @default.
• W2200671523 cites W2019207861 @default.
• W2200671523 cites W2021661404 @default.
• W2200671523 cites W2024236506 @default.
• W2200671523 cites W2024887507 @default.
• W2200671523 cites W2032288259 @default.
• W2200671523 cites W2039701074 @default.
• W2200671523 cites W2041648514 @default.
• W2200671523 cites W2043322419 @default.
• W2200671523 cites W2047760554 @default.
• W2200671523 cites W2054745605 @default.
• W2200671523 cites W2055399590 @default.
• W2200671523 cites W2061731602 @default.
• W2200671523 cites W2076942719 @default.
• W2200671523 cites W2077456314 @default.
• W2200671523 cites W2085990252 @default.
• W2200671523 cites W2092738402 @default.
• W2200671523 cites W2092931587 @default.
• W2200671523 cites W2099172258 @default.
• W2200671523 cites W2106971198 @default.
• W2200671523 cites W2120118174 @default.
• W2200671523 cites W2121042770 @default.
• W2200671523 cites W2123171945 @default.
• W2200671523 cites W2126571188 @default.
• W2200671523 cites W2128369457 @default.
• W2200671523 cites W2130934441 @default.
• W2200671523 cites W2133099653 @default.
• W2200671523 cites W2136295423 @default.
• W2200671523 cites W2136596547 @default.
• W2200671523 cites W2138691465 @default.
• W2200671523 cites W2138743737 @default.
• W2200671523 cites W2144860907 @default.
• W2200671523 cites W2156683343 @default.
• W2200671523 cites W2325707043 @default.
• W2200671523 cites W2337167731 @default.
• W2200671523 cites W2401709656 @default.
• W2200671523 cites W2620241325 @default.
• W2200671523 cites W4235961421 @default.
• W2200671523 cites W560372671 @default.
• W2200671523 doi "https://doi.org/10.1016/j.biomaterials.2015.12.018" @default.
• W2200671523 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4728024" @default.
• W2200671523 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26763733" @default.
• W2200671523 hasPublicationYear "2016" @default.
• W2200671523 type Work @default.
• W2200671523 sameAs 2200671523 @default.
• W2200671523 citedByCount "91" @default.
• W2200671523 countsByYear W22006715232016 @default.
• W2200671523 countsByYear W22006715232017 @default.
• W2200671523 countsByYear W22006715232018 @default.
• W2200671523 countsByYear W22006715232019 @default.
• W2200671523 countsByYear W22006715232020 @default.
• W2200671523 countsByYear W22006715232021 @default.
• W2200671523 countsByYear W22006715232022 @default.
• W2200671523 countsByYear W22006715232023 @default.
• W2200671523 crossrefType "journal-article" @default.
• W2200671523 hasAuthorship W2200671523A5004908033 @default.
• W2200671523 hasAuthorship W2200671523A5007381505 @default.
• W2200671523 hasAuthorship W2200671523A5021903894 @default.
• W2200671523 hasAuthorship W2200671523A5033300046 @default.
• W2200671523 hasAuthorship W2200671523A5033510051 @default.
• W2200671523 hasAuthorship W2200671523A5041411617 @default.
• W2200671523 hasAuthorship W2200671523A5042404397 @default.
• W2200671523 hasAuthorship W2200671523A5047498651 @default.
• W2200671523 hasAuthorship W2200671523A5081615205 @default.
• W2200671523 hasAuthorship W2200671523A5083728536 @default.
• W2200671523 hasBestOaLocation W22006715232 @default.
• W2200671523 hasConcept C121608353 @default.
• W2200671523 hasConcept C126322002 @default.
• W2200671523 hasConcept C142724271 @default.
• W2200671523 hasConcept C1491633281 @default.

• next